Skip to content

Arrow®

AC3 Optimus

Intra-Aortic Balloon Pump

IABP Performance Evolved

Simply outstanding performance

For patients requiring mechanical cardiac support, the performance of your IABP can mean all the difference. With the onset of an elevated heart rate or arrhythmia, the patient’s survival can suddenly depend on the ability of the IABP to keep pace with the situation.

The AC3 Optimus™ Intra-Aortic Balloon Pump provides intra-beat inflation timing accuracy across a wide range of patient conditions — including those with severe arrhythmias. 1-2

Request Virtual Demo
Download Brochure

Enhanced Value

Beyond its clinical value, the AC3 Optimus® IABP offers low cost of ownership. As budget pressures continue to grow, cost-effective
features like these become increasingly appealing:

  • Pneumatic drive system with no scheduled replacement parts

  • Low component replacement costs

Exceptional service

Teleflex is committed to providing attentive
and responsive support. In customer
surveys regarding Teleflex IABP service
programs:*

97.5%* of surveyed customers said their
service representative was knowledgeable
about our products and services

95%* of surveyed customers were overall satisfied with their last interaction with their customer service representative

95%* of surveyed customers said they were likely to refer others to Teleflex

IntraBeat Timing:
An advanced solution for a growing problem

To address a growing population of arrhythmic patients3, the AC3 Optimus® IABP features IntraBeat Timing. It determines individual AV closure points to provide remarkable accuracy during IABP support, even in patients with severe arrhythmias.1,4,5

The AC3 Optimus® IABP can help your facility be better equipped for your current and future patient populations.

The problem: The arrhythmic patient

The challenge: In published literature, conventional timing only showed 4 out of 16 beats were accurately timed.5

The solution: IntraBeat Timing has shown 98.1% accurately timed beats in severe arrhythmia.1

*Based on US customer surveys conducted by Teleflex.
 
References:

  1. Donelli A, Jansen JRC, Hoeksel B, et al. Performance of a real-time dicrotic notch detection and prediction algorithm in arrhythmic human aortic pressure signals. J Clin Monit.

    2002;17(3-4):181-185. Study sponsored by Teleflex.

  2. Torracca, L. Overcoming electro-surgical inference in IABP therapy with the combined use of AutoPilot and FiberOptix IAB sensor signal. 2007. (case report, data on file).  Study sponsored by Teleflex.

  3. Susan Colilla, PhD, MPHa, Ann Crow, MLSb, et al. Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population. Am J Cardiol.

    2013 Oct 15;112(8):1142-7

  4. Hoeksel S, Jansen J, Blom J, & Schreuder J,. Detection of dicrotic notch in arterial pressure signals. J Clin Monit. 1997;13(5),309-316. Study sponsored by Teleflex. Dr. Schreuder  was formerly a paid consultant of the study sponsor.

  5. Schreuder J, Castiglioni A, Donelli A, et al. Automatic intraaortic balloon pump timing using an intra beat dicrotic notch prediction algorithm. Ann Thorac Surg.  2005;79(3):1017-1022. Study sponsored by Teleflex. Dr. Schreuder was formerly a paid consultant of the study sponsor.

  6. Schreuder J, Maisano F, Donelli A, et al. Beat-to-beat effects of intra-aortic balloon pump timing on left ventricular performance in patients with low ejection fraction. Ann  Thorac Surg. 2005;79(3):872-880. Study sponsored by Teleflex. Dr. Schreuder was formerly a paid consultant of the study sponsor.

  7. Parissis et al. Intra aortic balloon pump: literature review of risk factors related to complications of the intraaortic balloon pump. Journal of Cardiothoracic Surgery 2011, 6:147

  8. Young-Seok Cho, Cheong Lim, et al. Should We Consider the Ethnic Difference in Selecting Size of Intraaortic Balloon by Commercial Guideline? ASAIO Journal 2009

  9. Ardawan Julian Rastan, MD, PhD; Eugen Tillmann, MD et al. Visceral Arterial Compromise During Intra-Aortic Balloon Counterpulsation Therapy. Circulation.  2010;122[suppl 1]:S92–S99

  10. Parissis, H, Soo, A, Leotsinidis, M, and Dougenis, D, A statistical model that predicts the length from the left subclavian artery to the celiac axis; towards accurate intra  aortic balloon sizing. Journal of Cardiothoracic Surgery. 2011, 6:95.

  11. Data on file


Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference.

Corporate Office

Phone +1 610 225 6800, 550 E. Swedesford Road, Suite 400, Wayne, PA 19087, USA

Regional Offices

International: Phone +353 (0)9 06 46 08 00, orders.intl@teleflex.com, Teleflex Medical Europe Ltd.,  IDA Business and Technology Park, Dublin Road, Athlone, Co Westmeath, Ireland

Australia: Phone 1300-360-226 (Domestic calls only), austCS@teleflex.com, Level 4, 197 Coward St Mascot NSW 2020 

New Zealand: Phone 0800 601 100 (Domestic calls only), nzcs@teleflex.com, 21 Airpark Drive, Mangere, Auckland 2022

For more information, please visit https://teleflex.com/anz

Teleflex, the Teleflex logo, Arrow, AC3 Optimus, AutoPilot, Protective Pumping and WAVE are trademarks or registered trademarks of Teleflex  Incorporated or its affiliates, in the U.S. and/or other countries.

Information in this material is not a substitute for the product Instructions for Use. Not all products may be available in all countries. Please contact your  local representative. Revised: 08/2019.

MC-101140.